The Video Journal of Hematology and Hematological Oncology / X
Jul 19, 2025, 19:00
Steven Treon on Promising Advances: 3 Novel Therapies Transforming Waldenström’s Macroglobulinemia
The Video Journal of Hematology and Hematological Oncology shared a post on X:
”What are some of the most exciting developments in the field of Waldenström’s macroglobulinemia? We caught up with Steven Treon of Dana-Farber Cancer Institute at 18 ICML to find out!”
Watch the interview here.
Dr. Steven Treon highlights promising advances in Waldenström’s macroglobulinemia, focusing on novel therapies like BTK degraders, that demonstrate strong efficacy, even in resistant cases, as well as non-covalent BTK inhibitors and BCL2 inhibitors.
His insights were shared at the 18th International Conference on Malignant Lymphoma in Lugano.
Latest scientific advancements in hematology highlighted in Hemostasis Today.
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT
-
Oct 9, 2026, 07:00Danny Reardon: Closing the Global Awareness Gap on Blood Clots
-
Oct 9, 2026, 00:54Mary Catherine Moffett: Advancing Advocacy Together – Highlights from the Sanofi Bleeding Disorders Summit